FDA posts lists of drugmakers it says may be ‘gaming’ the rules to thwart generic competition
admin 18th May 2018 Uncategorised 0The FDA is trying to “shame” drugmakers into cooperating with generics companies by posting a list of 52 drugs for which it says drugmakers reportedly refused to give competitors samples—a tactic it says is designed to keep drug prices high.
More: FDA posts lists of drugmakers it says may be ‘gaming’ the rules to thwart generic competition
Source: fierce